Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Clinuvel Pharmaceuticals Ltd (PK) CLVLF

Alternate Symbol(s):  CLVLY

Healthcare Biotechnology
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with... see more

Current News (PINL:CLVLF)

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

GlobeNewswire September 28, 2025

CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist

GlobeNewswire August 22, 2025

CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105

GlobeNewswire May 7, 2025

Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025

GlobeNewswire March 3, 2025

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

GlobeNewswire September 30, 2024

Afamelanotide in fair-skinned Parkinson's patients

GlobeNewswire June 17, 2024

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

GlobeNewswire March 28, 2024

Malibu shines a light on CLINUVEL's pioneering work in photomedicine

GlobeNewswire March 4, 2024

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

GlobeNewswire February 28, 2023
View More News ››

Opinion & Analysis (PINL:CLVLF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:CLVLF)

Be the first to post on this bullboard.

Geodrill Limited

Geodrill Limited

Geodrill Limited, together with its subsidiaries, provides mineral exploration drilling services to the mining companies in ...
View More »